🇺🇸 FDA
Pipeline program

BCMA-CART

2018-CART-00CH3(1)

Unknown mab terminated

Quick answer

BCMA-CART for Multiple Myeloma is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Multiple Myeloma
Phase
Unknown
Modality
mab
Status
terminated

Clinical trials